Medicare Enrolled
Dr. Lovrdu Pyreddy, M.D
Critical Care Medicine · Fresno, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Pyreddy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pyreddy?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Pyreddy
Dr. Lovrdu Pyreddy is a critical care medicine specialist in Fresno, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Pyreddy performed 4,068 Medicare services across 2,977 unique beneficiaries.
Between the years covered by Open Payments, Dr. Pyreddy received a total of $11,786 from 47 pharmaceutical and/or device companies across 716 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Pyreddy is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 5% volume in CA
$11,786 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,068
Medicare services
Top 5% in CA for critical care medicine
2,977
Unique beneficiaries
$68
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~214 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,386 | $96 | $166 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
307 | $9 | $39 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
286 | $67 | $115 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
259 | $94 | $195 |
| Spirometry test A test that measures the amount of air you can exhale and how fast you can blow it out. The provider evaluates the results to check lung function. |
256 | $19 | $40 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
255 | $31 | $150 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
255 | $46 | $100 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
253 | $36 | $100 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
223 | $6 | $30 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
214 | $17 | $106 |
| New patient office visit, complex (60-74 min) | 188 | $165 | $312 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
74 | $138 | $326 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
74 | $167 | $339 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
24 | $131 | $222 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
14 | $90 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$11,786
Total received (2018-2024)
Avg $1,684/year across 7 years
Top 12% in CA for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
716
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,663 (99.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$123 (1.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,639
2023
$1,924
2022
$1,901
2021
$1,498
2020
$1,158
2019
$1,548
2018
$2,118
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$370
AstraZeneca Pharmaceuticals LP
$361
Baxter Healthcare
$146
Philips North America LLC
$114
Merck Sharp & Dohme LLC
$98
Boehringer Ingelheim Pharmaceuticals, Inc.
$98
GENZYME CORPORATION
$92
Insmed, Inc.
$72
Paratek Pharmaceuticals, Inc.
$60
United Therapeutics Corporation
$57
Electromed, Inc.
$33
Regeneron Healthcare Solutions, Inc.
$32
Grifols USA, LLC
$29
Fisher & Paykel Healthcare Inc
$22
Actelion Pharmaceuticals US, Inc.
$22
Mylan Specialty L.P.
$18
Astellas Pharma US Inc
$18
Top 3 companies account for 53.5% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$2,693
AstraZeneca Pharmaceuticals LP
$1,885
Philips Electronics North America Corporation
$1,081
Boehringer Ingelheim Pharmaceuticals, Inc.
$966
Actelion Pharmaceuticals US, Inc.
$567
Insmed, Inc.
$350
United Therapeutics Corporation
$295
Baxter Healthcare
$274
Genentech USA, Inc.
$272
Electromed, Inc.
$246
Mallinckrodt Hospital Products Inc.
$239
Sunovion Pharmaceuticals Inc.
$229
Mylan Specialty L.P.
$214
Merck Sharp & Dohme LLC
$211
GENZYME CORPORATION
$206
Advanced Respiratory, Inc
$204
Regeneron Healthcare Solutions, Inc.
$182
Gilead Sciences, Inc.
$143
Grifols USA, LLC
$142
Janssen Pharmaceuticals, Inc
$124
Allergan Inc.
$119
Philips North America LLC
$114
Takeda Pharmaceuticals U.S.A., Inc.
$93
Resmed Corp
$92
Teva Pharmaceuticals USA, Inc.
$80
Bayer HealthCare Pharmaceuticals Inc.
$72
Paratek Pharmaceuticals, Inc.
$60
Merck Sharp & Dohme Corporation
$59
Harmony Biosciences LLC
$52
Fisher & Paykel Healthcare Inc
$46
Otsuka America Pharmaceutical, Inc.
$44
Amgen Inc.
$43
AbbVie Inc.
$42
Medtronic, Inc.
$38
Astellas Pharma US Inc
$37
E.R. Squibb & Sons, L.L.C.
$34
Circassia Pharmaceuticals Inc
$30
ADVANCED RESPIRATORY, INC
$29
Edwards Lifesciences Corporation
$25
PFIZER INC.
$24
EKOS Corporation
$23
Mallinckrodt LLC
$22
Shire North American Group Inc
$21
Inspire Medical Systems, Inc.
$18
Ceribell, Inc.
$16
Nabriva Therapeutics, plc
$15
ANI Pharmaceuticals, Inc.
$14
Top 3 companies account for 48.0% of all-time payments
Associated products mentioned in payments ›
(7999) SRC Und · (8874) inCourage · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · Adempas · AirDuo Digihaler · AirSense · Arikayce · Astral · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CHANTIX · CINQAIR · Cresemba · DUPIXENT · EKOSONIC · ELIQUIS · EV1000 Clinical Platform · Esbriet · FASENRA · FISHER & PAYKEL HEALTHCARE · GLASSIA · Health&WellnessUndiv · Hillrom - Life 2000 Ventilation System · Hillrom - Monarch Airway Clearance System · Hillrom - Vest System Model 105 Home Care · INCRUSE · INSPIRE · LONHALA MAGNAIR · Letairis · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · PURIFIED CORTROPHIN GEL · Perforomist · Prolastin-C · Prolastin-C Liquid · REMODULIN · Respiratoriy Care Undiv · Reveal LINQ · SAMSCA · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · Trilogy 100 · UPTRAVI · VERQUVO · WAKIX · WINREVAIR · Wakix · Wellcentive Undiv · XARELTO · Xenleta · Xolair · YUPELRI · Yupelri · ZERBAXA · inCourage · superDimension
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Critical care medicines within 10 mi
23
Per 100K population
2.3
County median income
$71,434
Nearest hospital
FRESNO SURGICAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Pyreddy is a clinical cardiology specialist, with above-average Medicare volume (top 5% in CA), with low-engagement industry engagement in the top 12% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Pyreddy experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Pyreddy performed 1,386 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pyreddy receive payments from pharmaceutical companies?
Yes. Dr. Pyreddy received a total of $11,786 from 47 companies across 716 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pyreddy's costs compare to other critical care medicines in Fresno?
Dr. Pyreddy's average Medicare payment per service is $68. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pyreddy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Critical Care Medicines in Fresno
Browse critical care medicines in Fresno ranked by procedure volume and transparency data.
Highest volume
Top Critical Care Medicines in CA
Critical care medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Critical Care Medicines in CA
Which CA critical care medicines receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Philips Electronics North America Corporation Payments to Doctors
See all physicians who received payments from Philips Electronics North America Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology